BBVA USA Bancshares’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$390K Buy
2,960
+129
+5% +$17.7K 0.02% 435
2020
Q4
$375K Buy
2,831
+95
+3% +$11.5K 0.02% 430
2020
Q3
$277K Sell
2,736
-69
-2% -$5.96K 0.02% 455
2020
Q2
$244K Buy
+2,805
New +$224K 0.01% 472
2020
Q1
Sell
-2,570
Closed -$237K 543
2019
Q4
$237K Buy
+2,570
New +$226K 0.01% 481
2019
Q3
Sell
-2,652
Closed -$313K 426
2019
Q2
$313K Buy
+2,652
New +$267K 0.02% 438

Other funds holding EXAS

BBVA USA Bancshares's EXAS Position: Q1 2021 in Review

BBVA USA Bancshares increased its Exact Sciences (EXAS) stake by 4.6% in Q1 2021, buying an estimated $17.7K and bringing the position to 2,960 shares worth $390K. The position accounts for 0.02% of the portfolio, ranked #435.

BBVA USA Bancshares first reported a position in EXAS in Q2 2019 and has held it in 6 quarters since. 646 funds tracked by Wall St. Rank hold EXAS as of Q1 2021.

  • BBVA USA Bancshares held 2,960 shares of Exact Sciences worth $390K as of Q1 2021.
  • BBVA USA Bancshares bought 129 Exact Sciences shares in Q1 2021, an estimated $17.7K.
  • Exact Sciences made up 0.02% of BBVA USA Bancshares's portfolio in Q1 2021, its #435 holding.
  • BBVA USA Bancshares first reported a position in Exact Sciences in Q2 2019 and has held it in 6 quarters since.
  • 646 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.